- Home
- APPS vs YDES Comparison
APPS vs YDES Comparison
Compare APPS & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APPS | YDES |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | |
| Sector | Miscellaneous | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.7M | 543.0M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | APPS | YDES |
|---|---|---|
| Price | $8.50 | $2.59 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | ★ 9.9M | 17.8K |
| Earning Date | 06-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $103,569,000.00 | N/A |
| Revenue This Year | $15.60 | N/A |
| Revenue Next Year | $11.34 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 38.55 | N/A |
| 52 Week Low | $2.74 | $2.38 |
| 52 Week High | $10.80 | $25.00 |
Technical Indicators
Market Signals| Indicator | APPS | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 59.51 | 26.93 |
| Support Level | $3.45 | N/A |
| Resistance Level | $10.80 | $5.36 |
| Average True Range (ATR) | 0.98 | 0.40 |
| MACD | -0.19 | -0.01 |
| Stochastic Oscillator | 20.07 | 2.74 |
Price Performance
Historical ComparisonAbout APPS Digital Turbine Inc.
Digital Turbine Inc is an independent mobile growth platform. It offers end-to-end products and solutions to all participants in the mobile application ecosystem, enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. Its operating segments are On Device Solutions and App Growth Platform.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.